Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SIGA Technologies (SIGA US)
Watchlist
23
Analysis
Health Care
•
United States
SIGA Technologies, Inc. operates as a commercial-stage pharmaceutical company. The Company offers oral formulation of an antiviral drug for the treatment of human smallpox disease caused by variola virus.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
SIGA Technologies
•
03 Oct 2022 19:03
•
Issuer-paid
SIGA Technologies - Second contract win from the US DoD in 2022
SIGA Technologies has announced a second procurement contract worth up to $10.7m from the US Department of Defense (DoD) for the procurement of...
Edison Investment Research
Follow
670 Views
Share
bullish
•
SIGA Technologies
•
27 Sep 2022 19:00
•
Issuer-paid
SIGA Technologies - Monkeypox concern drives international TPOXX win
SIGA Technologies (SIGA) has announced receipt of $16m of international procurement orders in the European Union (EU) and the Asia-Pacific region...
Edison Investment Research
Follow
670 Views
Share
bullish
•
SIGA Technologies
•
26 Sep 2022 19:04
•
Issuer-paid
SIGA Technologies - Monkeypox likely here to stay
With approximately 64k global cases, monkeypox has become a growing concern and is less transient than initially acknowledged. We expect SIGA...
Edison Investment Research
Follow
672 Views
Share
bullish
•
SIGA Technologies
•
11 Aug 2022 15:34
•
Issuer-paid
SIGA Technologies - BARDA exercises first option for IV TPOXX
Following strong Q222 results, SIGA Technologies has announced that the Biomedical Advanced Research and Development Authority (BARDA) has...
Edison Investment Research
Follow
388 Views
Share
First
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x